Literature DB >> 16002506

Radiofrequency ablation for the treatment of liver tumors in the caudate lobe.

Olivier Seror1, Djamel Haddar, Gisèle N'Kontchou, Yves Ajavon, Jean-Claude Trinchet, Michel Beaugrand, Nicolas Sellier.   

Abstract

PURPOSE: To evaluate the effectiveness of radiofrequency (RF) ablation for liver tumors located in the caudate lobe.
MATERIALS AND METHODS: Ten patients (46-79 years of age; median, 70 y), eight with hepatocellular carcinoma (HCC) and cirrhosis and two with colorectal metastases in the caudate lobe, were treated with 5.8% NaCl tissue-perfused monopolar (n=7) or bipolar (n=3) RF ablation. The median tumor diameter was 41 mm (range, 25-70 mm). Procedures were performed under ultrasound and computed tomography (CT) guidance in eight and two patients, respectively. One month later, the treatment response was assessed by CT.
RESULTS: Transhepatic right intercostal and transomental anterior epigastric routes were used for tumor puncture in eight and two patients, respectively. The entire RF ablation treatment required one or two procedures (median, 1.5), including two to 15 electrode repositionings (median, 6). After RF ablation procedure, one patient experienced jaundice that resolved spontaneously. In one patient, CT follow-up showed asymptomatic segmental biliary duct dilations. Median total hospital stay was 3 days (range, 2-9 d). Complete ablation was achieved in nine of 10 tumors. In one patient, ethanol ablation was necessary to complete RF ablation treatment. After a median follow up of 9.5 months (range, 5-25 mo), three patients remained tumor-free and seven had tumor relapse: two local, four distant, and one mixed. Repeat RF ablation was successfully performed in four cases.
CONCLUSION: RF ablation of liver tumors located in the caudate lobe is effective despite the deep location of tumors and the vicinity of major vessels.

Entities:  

Mesh:

Year:  2005        PMID: 16002506     DOI: 10.1097/01.RVI.0000159859.71448.8A

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  Caudate lobe amebic abscesses: percutaneous image-guided aspiration or drainage.

Authors:  Tanya Yadav; Ranjan K Patel; Akash Bansal; Navojit Chatterjee; Yashwant Patidar; Amar Mukund
Journal:  Abdom Radiol (NY)       Date:  2021-12-29

2.  Impact of Extended Use of Ablation Techniques in Cirrhotic Patients with Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.

Authors:  Toulsie Ramtohul; Valérie Vilgrain; Olivier Soubrane; Mohamed Bouattour; Alain Luciani; Hicham Kobeiter; Sébastien Mule; Vania Tacher; Alexis Laurent; Giuliana Amaddeo; Hélène Regnault; Julie Bulsei; Jean-Charles Nault; Pierre Nahon; Isabelle Durand-Zaleski; Olivier Seror
Journal:  Cancers (Basel)       Date:  2022-05-26       Impact factor: 6.575

3.  Hepatic radiofrequency under CT-fluoroscopy guidance.

Authors:  D Laganà; G Carrafiello; M Mangini; D Lumia; L Mocciardini; C Chini; G Pinotti; S Cuffari; C Fugazzola
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

4.  The sonographer's role in RFA therapy of liver lesions.

Authors:  S Mandarano; G Mandarano; Jh Sim
Journal:  Biomed Imaging Interv J       Date:  2009-01-01

Review 5.  Ultrasound-Guided Percutaneous Radiofrequency Ablation of Liver Tumors: How We Do It Safely and Completely.

Authors:  Jin Woong Kim; Sang Soo Shin; Suk Hee Heo; Jun Hyung Hong; Hyo Soon Lim; Hyun Ju Seon; Young Hoe Hur; Chang Hwan Park; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2015-10-26       Impact factor: 3.500

Review 6.  Advanced Techniques in the Percutaneous Ablation of Liver Tumours.

Authors:  Terrence Ch Hui; Justin Kwan; Uei Pua
Journal:  Diagnostics (Basel)       Date:  2021-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.